Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Ottawa

$60,000.00

Development of modified eggshell membrane formulations with enhanced immunomodulatory and anti-inflammatory activities to expand the non-food market for eggs.

EF 2021-22

Résumé
In developed countries such as Canada, about 30% of shell eggs are diverted to breaker processing plants for industrial production of egg white and yolk for the food processing and biopharmaceutical industries. However, large quantities of waste eggshell / eggshell membrane are generated for which the egg producing industry seeks high-value applications. The eggshell membrane (ESM) is approximately 1% of egg weight and consists of a bilayered proteinaceous fibrous meshwork, which is composed mainly of proteins (~90%), lipids (~3%), and carbohydrates (~2%). ESM fibers contain various structural proteins, including collagens and cysteine-rich eggshell membrane proteins (CREMPs), in addition to a significant content of bioactive proteins. ESM is considered a functionally equivalent extracellular matrix (ECM); however, it is greatly stabilized by extensive desmosine, isodesmosine, and disulfide cross-linkages, which challenge the identification of its protein constituents by standard proteomic approaches, and shield their activities. In spite of these difficulties, we have identified >500 protein constituents of ESM with numerous predicted biological functions such as antimicrobial, immunomodulatory and anti-inflammatory properties. However, specific processing approaches to yield highly active formulations of ESM material, and their mechanism of action, have not yet been satisfactorily achieved. In this Alliance grant application, we have partnered with Egg Farmers of Canada and Egg Farmers of Ontario (LRIC), as well as a major Canadian egg producer (Burnbrae Farms), to develop new processing methods to produce ESM with enhanced immunomodulatory and anti-inflammatory activities. This experimental program will lead to the development of modified ESM formulations to open new high-value markets for the Canadian poultry industry.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
556438-2020
Name nom
Hincke, Max
Department département
Cellular and Molecular Medicine
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2020
Award amount
60000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
5106
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Extra-cellular matrix
Research subject fr
Matrice extra-cellulaire
Installment
inst:2
Partie
1
Nb partie
2
Application title
Development of modified eggshell membrane formulations with enhanced immunomodulatory and anti-inflammatory activities to expand the non-food market for eggs.
Keyword
NSERC
Application summary
In developed countries such as Canada, about 30% of shell eggs are diverted to breaker processing plants for industrial production of egg white and yolk for the food processing and biopharmaceutical industries. However, large quantities of waste eggshell / eggshell membrane are generated for which the egg producing industry seeks high-value applications. The eggshell membrane (ESM) is approximately 1% of egg weight and consists of a bilayered proteinaceous fibrous meshwork, which is composed mainly of proteins (~90%), lipids (~3%), and carbohydrates (~2%). ESM fibers contain various structural proteins, including collagens and cysteine-rich eggshell membrane proteins (CREMPs), in addition to a significant content of bioactive proteins. ESM is considered a functionally equivalent extracellular matrix (ECM); however, it is greatly stabilized by extensive desmosine, isodesmosine, and disulfide cross-linkages, which challenge the identification of its protein constituents by standard proteomic approaches, and shield their activities. In spite of these difficulties, we have identified >500 protein constituents of ESM with numerous predicted biological functions such as antimicrobial, immunomodulatory and anti-inflammatory properties. However, specific processing approaches to yield highly active formulations of ESM material, and their mechanism of action, have not yet been satisfactorily achieved. In this Alliance grant application, we have partnered with Egg Farmers of Canada and Egg Farmers of Ontario (LRIC), as well as a major Canadian egg producer (Burnbrae Farms), to develop new processing methods to produce ESM with enhanced immunomodulatory and anti-inflammatory activities. This experimental program will lead to the development of modified ESM formulations to open new high-value markets for the Canadian poultry industry.